Peptide Synthesis Market Booming at 8% CAGR, Set to Reach US$1.1 Billion by 2033 | FMI Study Report

Peptide Synthesis Market

The Peptide Synthesis Market is experiencing a surge in growth, driven by its increasing importance in both research and therapeutic applications. According to a recent market analysis by Future Market Insights (FMI), a leading market research firm, the market is poised for a significant expansion. Currently valued at an estimated US$520.0 million in 2023, the market is projected to climb steadily at a Compound Annual Growth Rate (CAGR) of 8%. This positive trajectory indicates a bright future for the peptide synthesis industry, with a projected valuation reaching an impressive US$1.1 billion by 2033.

The rising prevalence of metabolic illnesses and chronic diseases such as diabetes, oncology, and obesity is driving this unprecedented growth. This development emphasizes the crucial need for novel medical solutions, with peptide synthesis emerging as a key component. Its broad chemical diversity, powerful biological activity, and low toxicity make it an ideal choice for the development of cutting-edge healthcare solutions.

The market’s expansion is further fueled by the escalating demand for pharmacological components in medication. As the need for treatments targeting cardiovascular, neurological, and renal failures continues to grow, the significance of peptide synthesis in the pharmaceutical landscape becomes increasingly evident.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-14257

Governments’ initiative programs, advanced healthcare therapy with adopting the latest technology, and research and development activities are further surging the market opportunities.

Rising consumer healthcare and pharmaceutical sectors are increasing the demand for peptide synthesis. Moreover, the growing malignancies, uneven lifestyles, and deadly diseases propel market opportunities. Due to its effective result, the growing popularity of enzymatic technology upsurges market growth among patients.

How Key Players Faced Threats in the Peptide Synthesis Market?

Due to the lack of a peptide purification system, several therapeutic peptides go through the parenteral route. The adoption of peptide synthesis medications are widely used to treat a chronic illness for a long period of treatment, may face a problem for key players. Enzymatic breakdown and limited intestinal mucosa are a few causes of adopting oral peptide drugs.

These medicines have poor lipophilicity and charged functional groups, which are difficult to handle or absorb. However, several peptide synthesis companies are given that peptides have short half-lives and limited bioavailability. Fast metabolism and conformational changes restrict protein therapies and the bioavailability of peptides.

Pharmaceutical and Biotechnology Sectors Leading the Market Growth

Growing research and development activities, low-cost therapies, and efficient and low toxicity are a few important factors that propel market growth. The significantly growing advanced technology in the pharmaceutical and biotechnology sectors is driving peptide synthesis market expansion.

In 2022, according to Science Direct, advanced oral drugs treated diabetes patients through peptide medications. Moreover, in Jan 2022, Novo Nordisk launched its new and world’s first diabetes management ‘peptide in a pill’.All these developments are boosting the pharmaceutical and biotechnology sectors.

Increasing Patients of Chronic Disease Dominates the United States Market

The United States is leading the global market by capturing an impressive CAGR of 7.8% during the foreseen time. Increasing chronic patients, including cardiovascular and diabetes, are fostering market growth. The rising demand for peptide-based vaccines is increasing the demand for peptide synthesis.

According to a report by the American Cancer Society, around 1.9 million new cancer cases grew in the United States. The innovation of new drugs, rising government policies, and new market entrance are surging the United States peptide synthesis market opportunities.

Peptide Synthesis Market Key Takeaways:

• The peptide synthesis market is expected to have a valuation of US$ 1.1 billion by 2033.
• With a CAGR of 8%, the global market increasing from 2022 to 2033.
• The United States peptide synthesis market is anticipated to record a CAGR of 7.8% through 2033.
• With a CAGR of 7.1%, the United Kingdom market significantly uplifts during the forecast period.
• China’s market is expected to hold a CAGR of 7.4% over the forecast period.
• Japan’s market captured a CAGR of 6.5% from 2023 to 2033.

Peptide Synthesis Market Competitive Landscape:

The present prominent players fragmented the market. These players invested a huge amount in research and development activities to acquire maximum output. Through their marketing strategies, these prominent players upsurge the market growth.

Peptide Synthesis Market Key Players:

• GenScript Biotech Corporation
• Bachem Holding AG
• Thermo Fisher Scientific Inc
• Merck KGaA
• Kaneka Corporation

Level Up Your Market Understanding – Purchase Now!
https://www.futuremarketinsights.com/checkout/14257

Peptide Synthesis Market Recent Developments:

• In June 2020, Evonik announced its new peptide, which is highly soluble and chemically defined to supply amino acids.
• In May 2022, the United States Food and Drug Administration approved the Mounjaro injection that helps to control blood sugar and type 2 diabetes disease.

Peptide Synthesis Market by Category

By Product and Services:

• Reagents
• Equipment
• Services

By Technology:

• Solid-phase peptide Synthesis
• Solution-phase Peptide Synthesis
• Hybrid & Recombinant Technology

By End Use:

• Pharmaceuticals & Biotechnology Companies
• CDMOs & CROs
• Academics & Research Institutes

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube